Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Adult male patients (≥ 18 years old)
with metastatic castration-resistant prostate cancer,
who have initiated olaparib within at least, the last two months of study entry, at their physician's discretion or who have been enrolled in the funded early access program
who have been informed and are not opposed to their data collection --- For Patients initiated with olaparib in fEA,
* Still alive and who have been informed verbally and/or in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control (certified by physician);
* who deceased and who did not object to data collection for research purpose(s) during his or her lifetime.
You may not be if
Patients opposed to the collection of their data
Patients participating in a clinical trial with an investigational prostate cancer targeted drug within 30 days prior to Olaparib initiation
